Background: Alzheimer’s disease (AD) may develop 10-15 years before onset of mild cognitive impairment (MCI). Early intervention may serve to halt or delay disease progression. Thus, there is a need to investigate early cognitive and biological markers to detect and track disease progression. Subjective cognitive decline (SCD) is an established risk-factor for AD. However, SCD is a common phenomenon ...